CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 6 enrolled
Drug / intervention
[^14C]-LY2940680drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01746745
NCT01746745Phase 1Completed
CompareCT.gov

Disposition of [14C]-LY2940680 Following Oral Administration in Healthy Subjects

Eli Lilly and Company·interventional·Posted Dec 11, 2012·Updated Jul 22, 2019

In Brief

A Phase 1 clinical trial evaluating [^14C]-LY2940680 for Healthy Volunteers. Completed, enrolled 6 participants across 1 site.

Detailed Summary

This is a single dose study of radiolabelled LY2940680 taken by mouth in healthy participants to study how the body absorbs and removes LY2940680 from the blood. This study is for research purposes only and is not intended to treat any medical condition.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 11, 2012
Enrollment StartJan 1, 2013
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 13.6 years ago

Interventions

[^14C]-LY2940680drug

Administered as solution by mouth